Abstract
Torque teno (TT) viruses have been more frequently reported in malignant biopsies when compared to normal control tissue. The possible contribution of TT virus infection to human carcinogenesis or the potential oncolytic functions of these virus infections are being discussed based on available experimental evidence. The data could suggest an involvement of TT virus infections as an indirect carcinogen by modulating T cell immune responses. Significant oncolytic functions, potentially mediated by the inhibition of nuclear factor (NF)-кB transcription factor or by apoptin-like gene activities, are emerging to be less likely.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Alvaro T, Lejeune M, Salvado MT, et al (2006) Immunohistochemical patterns of reactive micro-environment are associated with clinicobiologic behaviour in follicular lymphoma patients. J Clin Oncol 25:5350–5357
Bagaglio S, Sitia G, Prati D, Cella D, Hasson H, Novati R, Lazzarin A, Morsica G (2002) Mother-to-child transmission of TT virus: sequence analysis of non-coding region of TT virus in infected mother-infant pairs. Arch Virol 147:803–812
Bendinelli M, Maggi F (2005) TT virus and other anelloviruses. In: Mahy B, ter Meulen V (eds) Topley and Wilson: microbiology and microbial infections. Arnold Press, London
Camci C, Guney C, Balkan A, et al (2002) The prevalence of TT virus in cancer patients. New Microbiol 25:463–468
Chayama K, Kobayashi M, Tsubota A, et al (1999) Susceptibility of TT virus to interferon therapy. J Gen Virol 80:631–634
Christensen JK, Eugen-Olsen J, Sorensen M, et al (2000) Prevalence and prognostic significance of infection with TT virus in patients infected with human immunodeficiency virus. J Infect Dis 181:1796–1799
de Villiers EM, Schmidt R, Delius H, et al (2002) Heterogeneity of TT virus related sequences isolated from human tumour biopsy specimens. J Mol Med 80:44–50
de Villiers EM, Bulajic M, Nitsch C, et al (2007) TTV infection in colorectal cancer tissues and normal mucosa. Int J Cancer 121:2109–2112
Desai M, Pal R, Deshmukh R, et al (2005) Replication of TT virus in hepatocyte and leucocyte cell lines. J Med Virol 77:136–143
Feng H, Shuda M, Chang Y, et al (2008) Clonal integration of a polyomavirus in human Merkel cell carcinoma. Science 319:1096–1100
Focosi D, Petrini M (2007) CD57 expression on lymphoma microenvironment as a new prognostic marker to immune dysfunction. J Clin Oncol 25:1289–1291
Girard C, Ottomani L, Ducos J, et al (2007) High prevalence of Torque teno (TT) virus in classical Kaposi's sarcoma. Acta Derm Venereol 87:14–17
Gutierrez A, Munoz I, Solano C, et al (2003) Reconstitution of lymphocyte populations and cytomegalovirus viremia or disease after allogeneic peripheral blood stem cell transplantation. J Med Virol 70:399–403
Handa A, Dickstein B, Young NS, et al (2000) Prevalence of the newly described human circovirus, TTV, in United States blood donors. Transfusion 40:245–251
Indolfi G, Moriondo M, Galli L, et al (2007) Mother-to-infant transmission of multiple blood-borne viral infections from multi-infected mothers. J Med Virol 79:743–747
Jackson S, Storey A (2000) E6 proteins from diverse cutaneous HPV types inhibit apoptosis in response to UV damage. Oncogene 19:592–598
Jelcic I, Hotz-Wagenblatt A, Hunzicker A, et al (2004) Isolation of multiple TT virus genotypes from spleen biopsy tissue from a Hodgkin's disease patient: genome reorganization and diversity of the hypervariable region. J Virol 78:7498–7507
Kanda Y, Tanaka Y, Kami M, et al (1999) TT virus in bone marrow transplant recipients. Blood 93:2485–2490
Kooistra K, Zhang YH, Henriquez NV, et al (2004) TT virus-derived apoptosis inducing protein induces apoptosis preferentially in hepatocellular carcinoma cell lines. J Gen Virol 85:1445–1450
Leppik L, Gunst K, Lehtinen M, Dillner J, Streker K, de Villiers EM (2007) In vivo and in vitro intragenomic rearrangement of TT viruses. J Virol 81:9346–9356
Maggi F, Pistello M, Vatteroni M, et al (2001) Dynamics of persistent TT virus infection, as determined in patients treated with alpha interferon for concomitant hepatitis C virus infection. J Virol 75:11999–12004
Maggi F, Pifferi M, Tempestini E, et al (2003) TT virus loads and lymphocyte subpopulations in children with acute respiratory diseases. J Virol 77:9081–9083
Maggi F, Focosi D, Ricci V, et al (2008) Changes in CD8 +57+ T lymphocyte expansions after autologous hematopoietic stem cell transplantation correlate with changes in torquetenovirus viremia. Transplantation (in press)
Mariscal LF, Lopez-Alcorocho JM, Rodriguez-Inigo E, et al (2002) TT virus replicates in stimulated but not in nonstimulated peripheral blood mononuclear cells. Virology 301:121–129
Moen EM, Sagedal S, Bjoro K (2003) Effect of immune modulation on TT virus (TTV) and TT-like-mini-virus (TMLV) viremia. J Med Virol 70:177–182
Naugler WE, Karin M (2008) NF-kappaB and cancer-identifying targets and mechanisms. Curr Opin Genet Dev 18:19–26
Nishizawa T, Okamoto H, Tsuda F, et al (1999) Quasispecies of TT virus (TTV) with sequence divergence in hypervariable regions of the capsid protein in chronic TTV infection. J Virol 73:9604–9608
Nishizawa Y, Tanaka E, Orii K, et al (2000) Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon. J Gastroenterol Hepatol 15:1292–1297
Okamoto H, Nishizawa C, Tawara A, et al (2000a) TT virus mRNAs detected in the bone marrow cells from an infected individual. Biochem Biophys Res Commun 279:700–707
Okamoto H, Takahashi M, Nishizawa C, et al (2000b) Replicative forms of TT virus DNA in bone marrow cells. Biochem Biophys Res Commun 270:657–662
Raykov Z, Rommelaere J (2008) Potential of tumour cells for delivering oncolytic viruses. Gene Ther 15:704–710
Roullet MR, Bagg A (2007) Recent insights into the biology of Hodgkin lymphoma: unraveling the mysteries of the Reed-Sternberg cell. Expert Rev Mol Diagn 7:805–820
Sagir A, Adams O, Oette M, et al (2005) SEN virus seroprevalence in HIV positive patients: association with immunosuppression and HIV replication. J Clin Virol 33:183–187
Sherman KE, Rousters SD, Feinberg J (2001) Prevalence and genotypic variability of TTV in HIV-infected patients. Dig Dis Sci 46:2401–2407
Shibayama T, Masuda G, Ajisawa A, et al (2001) Inverse relationship between the titre of TT virus DNA and CD4 cell count in patients infected with HIV. AIDS 15:563–570
Simmonds P (2002) TT virus infection: a novel virus-host relationship. J Med Microbiol 51:455–458
Thom K, Petrik J (2007) Progression towards AIDS leads to increased torque teno virus and torque teno minivirus titers in HIV infected individuals. J Med Virol 79:1–7
Touinssi M, Gallian P, Biagini P, et al (2001) TT virus infection: prevalence of elevated viraemia and arguments for the immune control of viral load. J Clin Virol 21:135–141
Toyoda H, Fukuda Y, Yokozaki S, et al (1999) Interferon treatment of two patients with quadruple infection with hepatitis C virus (HCV), human immunodeficiency virus (HIV), hepatitis G virus (HGV), and TT virus (TTV). Liver 19:438–444
Tsuda S, Okamoto H, Ukita M, et al (1999) Determination of antibodies to TT virus (TTV) and application to blood donors and patients with post-transfusion non-A to G hepatitis in Japan. J Virol Methods 77:199–206
Xin X, Xiaoguang Z, Ninghu Z, et al (2004) Mother-to-infant vertical transmission of transfusion transmitted virus in South China. J Perinat Med 32:404–406
Zheng H, Ye L, Fang X, et al (2007) Torque teno virus (SANBAN isolate) ORF2 protein suppresses NF-kappaB pathways via interaction with IkappaB kinases. J Virol 81:11917–11924
Zhong S, Yeo W, Tang M, et al (2002) Frequent detection of the replicative form of TT virus DNA in peripheral blood mononuclear cells and bone marrow cells in cancer patients. J Med Virol 66:428–434
zur Hausen H (2006) Infections causing human cancer. Wiley-VCH, Weinheim, New York
zur Hausen H, de Villiers EM (2005) Virus target cell conditioning model to explain some epidemiologic characteristics of childhood leukemias and lymphomas. Int J Cancer 115:1–5
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
zur Hausen, H., Villiers, EM.d. (2009). TT Viruses: Oncogenic or Tumor-Suppressive Properties?. In: de Villiers, EM., Hausen, H.z. (eds) TT Viruses. Current Topics in Microbiology and Immunology, vol 331. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-70972-5_7
Download citation
DOI: https://doi.org/10.1007/978-3-540-70972-5_7
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-70971-8
Online ISBN: 978-3-540-70972-5
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)